BD SafetyGlide™ 0.5 mL 29G 12.7 mm Insulin Syringe Pack of 100
Becton Dickinson
Medical deviceSafety insulin syringe with fixed needle
Certifications
- CE marked medical device, Class IIa (Directive 93/42/EEC), CE 0050 (per BD technical documentation covering BD SafetyGlide™ insulin syringes including ref. 305932)
- Conforms to ISO 8537: Sterile single Use syringes for insulin
- Conforms to ISO 7864: Sterile hypodermic needles for single use
- Conforms to ISO 9626: Stainless steel needle tubing for the manufacture of medical devices
- Conforms to EN 1041: Information supplied by the manufacturer of medical devices
- Sterile, single Use device
- Latex Free
- CE marked medical device, Class IIa (Directive 93/42/EEC), CE 0050 (per BD technical documentation covering BD SafetyGlide™ insulin syringes including ref. 305932)
- Conforms to ISO 8537: Sterile single Use syringes for insulin
- Conforms to ISO 7864: Sterile hypodermic needles for single use
- Conforms to ISO 9626: Stainless steel needle tubing for the manufacture of medical devices
- Conforms to EN 1041: Information supplied by the manufacturer of medical devices
- Sterile, single Use device
- Latex Free
Safety insulin syringe with fixed needle
Description
BD SafetyGlide™ 0.5 mL 29G 12.7 mm Insulin Syringes are sterile, single-use safety-engineered insulin syringes with a permanently attached 29G (0.33 mm) needle and U-100 insulin graduations. The integrated sliding SafetyGlide™ shield is activated with one hand immediately after injection, helping protect healthcare professionals and caregivers from accidental needlestick injuries while maintaining patient comfort. The syringes are latex-free, supplied in individual blister packs, and intended for subcutaneous injection of U-100 insulin. Each box contains 100 syringes; BD catalog reference 305932.
Bnefits
- Safety-engineered sliding shield designed to reduce needlestick injury risk
- One-handed safety activation with minimal change in injection technique
- Permanently attached 29G x 1/2 in (12.7 mm) stainless steel needle for subcutaneous insulin delivery
- U-100 insulin graduations for accurate insulin dosing up to 0.5 mL (50 IU)
- Latex-free construction to reduce risk of latex-related hypersensitivity
- Sterile, single-use device to help prevent cross-contamination
- Regular-wall, regular-bevel needle designed for smooth skin penetration
- Individually blister-packed for aseptic presentation
- Recognised BD brand quality with technical data sheet and IFU support
Indications
- Subcutaneous injection of U-100 insulin using a 0.5 mL insulin syringe
- Use in patients requiring insulin therapy for diabetes, in clinical or home-care settings
- Settings where safety-engineered sharps devices are recommended to reduce needlestick risk (e.g. hospitals, clinics, primary care, diabetes clinics, medical aesthetics practices treating insulin-dependent patients)
Composition
- Barrel: plastic syringe body (medical-grade polymer)
- Plunger: plastic plunger with elastomeric stopper
- Needle: stainless steel, 29G (external diameter 29G, length 13 mm / 0.5 in)
- Needle wall type: regular wall
- Needle tip type: regular bevel for subcutaneous injection
- Integrated BD SafetyGlide™ sliding safety shield attached to the needle hub
- Latex-free components
- Sterile product supplied in individual blister packaging
Formulation
- Device type: sterile safety insulin syringe with permanently attached needle
- Fill volume: 0.5 mL (50 IU U-100 scale)
- Graduations: U-100 insulin units
- Needle gauge and length: 29G x 1/2 in (0.33 mm x 13 mm, 12.7 mm nominal)
- Needle application: subcutaneous injection
Packaging
- Primary packaging: individual sterile blister pack per syringe
- Shelf box: 100 syringes per box
- Shipping case (manufacturer configuration): 400 syringes (4 boxes of 100) per shipping carton (per BD technical data sheet)
- Blister pack labelling includes product identification, gauge, length and U-100 insulin scale
- Retail listing: Pack of 100 syringes
Usage
- Verify product details (volume 0.5 mL, 29G x 12.7 mm, U-100 insulin) on the packaging before use.
- Inspect the blister pack; do not use if the package is damaged, opened or the sterility is compromised.
- Open the blister aseptically and remove the sterile syringe immediately before use.
- Draw up the prescribed dose of U-100 insulin using the U-100 unit scale on the barrel.
- For subcutaneous injection, prepare the injection site according to local protocol (e.g. clean skin and allow to dry).
- Pinch or gently lift the skin fold if required and insert the needle subcutaneously (29G x 12.7 mm) at an appropriate angle (commonly 90° or as per clinical guidance).
- Depress the plunger fully to deliver the full insulin dose.
- While withdrawing the needle from the patient, activate the BD SafetyGlide™ shield using the one-handed activation technique recommended in the BD instructions (slide or press the shield forward until it locks with an audible or tactile click).
- Confirm that the safety shield is locked over the needle and the needle tip is fully covered.
- Immediately discard the used, shielded syringe into an approved sharps disposal container; do not recap, bend or manually remove the needle.
- Do not reuse; this is a sterile, single-use device.
Contraindications
Not publicly listed
Adverse Effects
Not publicly listed
Storage Conditions
- Store in a clean, dry environment at room temperature as indicated on the packaging.
- Keep syringes in their original packaging until use to maintain sterility.
- Protect from excessive heat, moisture and direct sunlight.
- Keep out of reach of children and unauthorised users.
